Mesoblast (MESO) Depreciation & Amortization (CF) (2016 - 2025)

Mesoblast's (MESO) quarterly Depreciation & Amortization (CF) came in at $2.1 million in Q2 2025, down 14.82% year-on-year from $2.4 million in Q2 2024, and down 14.82% quarter-over-quarter from $2.4 million in Q2 2024.

Mesoblast (MESO) Depreciation & Amortization (CF) (2016 - 2025) Analysis & Trends

Mesoblast has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $2.1 million for Q2 2025.

  • Depreciation & Amortization (CF) for Q2 2025 came in at $2.1 million, down 14.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.5 million (down 2.35% YoY), and the FY2025 annual result was $2.1 million, down 14.82% from the prior year.
  • Depreciation & Amortization (CF) came in at $2.1 million for Q2 2025 at Mesoblast, down from $2.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.3 million in Q2 2022 to a low of $990000.0 in Q1 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $1.1 million (2022), against an average of $1.7 million.
  • Across the five-year window, Depreciation & Amortization (CF) rose 17.81% in 2021 and tumbled 33.82% in 2023, its largest moves.
  • Mesoblast's Depreciation & Amortization (CF) stood at $1.1 million in 2021, then fell by 1.54% to $1.1 million in 2022, then soared by 101.84% to $2.2 million in 2023, then increased by 11.55% to $2.4 million in 2024, then retreated by 14.82% to $2.1 million in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $2.1 million (Q2 2025), $2.4 million (Q2 2024), and $2.2 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Mesoblast 21.68 Bn 21.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 2.08 Mn
Jun 30, 2025 2.08 Mn
Jun 30, 2024 2.44 Mn
Jun 30, 2024 2.44 Mn
Jun 30, 2023 2.19 Mn
Jun 30, 2023 2.19 Mn
Mar 31, 2023 990,000.00
Mar 31, 2023 990,000.00
Dec 31, 2022 1.09 Mn
Dec 31, 2022 1.09 Mn
Sep 30, 2022 1.11 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 3.31 Mn
Jun 30, 2022 3.31 Mn
Mar 31, 2022 1.11 Mn
Mar 31, 2022 1.11 Mn
Dec 31, 2021 1.10 Mn
Dec 31, 2021 1.10 Mn
Sep 30, 2021 1.09 Mn
Sep 30, 2021 1.09 Mn